Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ahmer11
    Junior Member
    • Dec 2014
    • 2

    Introduction - new to NGS world

    Hi

    We are currently exploring purchasing a MiSeq for clinical use. We are looking at some oncogenes and other targets for Diagnosis and Companion Diagnosis.

    Thank you
    Ahmer
  • shreedivya
    Junior Member
    • Jun 2018
    • 5

    #2
    Hi everyone .Please explain me about this forum.
    Hi I am anushka. I am working as a Manager in Hotel temple citi

    Comment

    • Gabriela Levy
      Junior Member
      • Aug 2018
      • 1

      #3
      Hi to everyone - New on NGS

      Hello! I am planning to perform several Chip-seq assays.
      I would like to know which service facility do you recommend with low cost.
      Do I need three independent samples of Input and chip? or maybe two?
      Thank you in advance!!
      gaabriela

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        @Gabriela: Take a look at http://allseq.com/ and https://genohub.com/ to do comparison shopping for sequencing prices.

        You should always have at least 3 (or more if possible) biological replicates to have the ability to drwa reasonable statistical inference from your samples.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          Today, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 11:10 AM
        0 responses
        7 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        29 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        38 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Working...